KRASG12D-Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients

Valerie S. LeBleu, Brandon G. Smaglo, Krishnan K. Mahadevan, Michelle L. Kirtley, Kathleen M. McAndrews, Mayela Mendt, Sujuan Yang, Ana S. Maldonado, Hikaru Sugimoto, Maria E. Salvatierra, Luisa M Solis Soto, Rick Finch, Mihai Gagea, Adam C. Fluty, Steve J. Ludtke, J Jack Lee, Abhinav K. Jain, Gauri Varadhachary, Rachna T Shroff, Anirban Maitra, Elizabeth Shpall, Raghu Kalluri, Shubham Pant
doi: https://doi.org/10.1101/2025.03.03.25322827

Article Information

doi 
https://doi.org/10.1101/2025.03.03.25322827
History 
  • March 6, 2025.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Valerie S. LeBleu1,2,#,*,
  2. Brandon G. Smaglo3,*,
  3. Krishnan K. Mahadevan1,*,
  4. Michelle L. Kirtley1,
  5. Kathleen M. McAndrews1,
  6. Mayela Mendt4,
  7. Sujuan Yang1,
  8. Ana S. Maldonado1,
  9. Hikaru Sugimoto1,
  10. Maria E. Salvatierra5,
  11. Luisa M Solis Soto5,
  12. Rick Finch6,
  13. Mihai Gagea7,
  14. Adam C. Fluty8,
  15. Steve J. Ludtke8,
  16. J Jack Lee9,
  17. Abhinav K. Jain10,
  18. Gauri Varadhachary3,†,
  19. Rachna T Shroff11,
  20. Anirban Maitra12,13,
  21. Elizabeth Shpall4,
  22. Raghu Kalluri1,13,14,# and
  23. Shubham Pant3,15,#
  1. 1Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX
  2. 2Department of Internal Medicine, Baylor College of Medicine, Houston, TX
  3. 3Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
  4. 4Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
  5. 5Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
  6. 6Department of Comparative Medicine, MD Anderson Cancer Center, Bastrop, TX 78602
  7. 7Department of Veterinary Medicine and Surgery, University of Texas MD Anderson Cancer Center, Houston, TX
  8. 8Verna Marrs and McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX
  9. 9Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
  10. 10Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX
  11. 11Division of Hematology/Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, AZ
  12. 12Department of Pathology and Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX
  13. 13Department of Bioengineering, Rice University, Houston, TX
  14. 14Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX
  15. 15Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
  1. ↵#Co-corresponding authors Contact author: Valerie LeBleu, vlebleu{at}mdanderson.org
Back to top
Posted March 06, 2025.
Download PDF

Supplementary Material

Data/Code
Email
KRASG12D-Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients
Valerie S. LeBleu, Brandon G. Smaglo, Krishnan K. Mahadevan, Michelle L. Kirtley, Kathleen M. McAndrews, Mayela Mendt, Sujuan Yang, Ana S. Maldonado, Hikaru Sugimoto, Maria E. Salvatierra, Luisa M Solis Soto, Rick Finch, Mihai Gagea, Adam C. Fluty, Steve J. Ludtke, J Jack Lee, Abhinav K. Jain, Gauri Varadhachary, Rachna T Shroff, Anirban Maitra, Elizabeth Shpall, Raghu Kalluri, Shubham Pant
medRxiv 2025.03.03.25322827; doi: https://doi.org/10.1101/2025.03.03.25322827
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area